SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KHS who wrote (21373)4/26/1999 12:45:00 PM
From: VLAD  Read Replies (1) of 23519
 
KHS,

On level II Cruttedon Roth has been buying all morning long and even now as I type they are first in line on the bid at 4 9/16.

When Wole Fayemi left CRUT they turned coverage over to Curtis Hogue and moved the rating from "arbitrage" to hold. Curtis Hogue left CRUT and there has been no analyst actively covering.

VLAD thinks that CRUT will soon announce a new analyst to be covering Vivus with an upgrade to accumulate. I also suspect that coverage by a new brokerage may just beat CRUT to the punch on this one. We shall see.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext